This compound is a benzimidazole derivative featuring a difluorinated chromane ether side chain. It is primarily utilized as a research reagent in pharmaceutical development, with its structure suggesting potential for studying receptor interactions or biochemical pathways.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2351939-46-1
7-[(5,7-Difluorochroman-4-yl)oxy]-2-methyl-1H-benzo[d]imidazole-5-carboxylic Acid
Pharmaceutical intermediate
Tegoprazan
potassium-competitive acid blocker
(4R)-Tegoprazan
active pharmaceutical ingredient
Loratadine N-Oxide
pharmaceutical research compound
4-(4-Cyano-2-methoxyphenyl)-2,8-dimethyl-5-oxo-1,4,5,6-tetrahydro-1,6-naphthyridine-3-carboxamide
pharmaceutical research compound
1-oxa-3,8-diazaspiro[4.5]decan-2-one hydrochloride
pharmaceutical research compound
Benzoic acid, 4-(2-(octyloxy)benzamido)-, 2-(diethylamino)ethyl ester hydrochloride
pharmaceutical research compound
N-isopropyl-2-nitrobenzenesulfonamide
research compound
7-[(5,7-difluoro-3,4-dihydro-2H-chromen-4-yl)oxy]-N,2-dimethyl-3H-benzimidazole-5-carboxamide
XSFQYWLWWMLNHM-UHFFFAOYSA-N
CC1=NC2=C(N1)C=C(C=C2OC3CCOC4=C3C(=CC(=C4)F)F)C(=O)NC